Avid Bioservices, Inc. (CDMO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 521.17M |
| Enterprise value | 685.36M |
| Trailing P/E | 9.41 |
| Forward P/E | 88.50 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.81 |
| Price/book (mrq) | 2.89 |
| Enterprise value/revenue | 5.01 |
| Enterprise value/EBITDA | -87.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.62 |
| 52-week change 3 | -55.77% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 18.86 |
| 52-week low 3 | 4.07 |
| 50-day moving average 3 | 7.05 |
| 200-day moving average 3 | 8.00 |
Share statistics
| Avg vol (3-month) 3 | 1.38M |
| Avg vol (10-day) 3 | 1.26M |
| Shares outstanding 5 | 63.48M |
| Implied shares outstanding 6 | 63.24M |
| Float 8 | 55.35M |
| % held by insiders 1 | 1.10% |
| % held by institutions 1 | 96.55% |
| Shares short (15 Apr 2024) 4 | 10.32M |
| Short ratio (15 Apr 2024) 4 | 8.76 |
| Short % of float (15 Apr 2024) 4 | 19.40% |
| Short % of shares outstanding (15 Apr 2024) 4 | 16.26% |
| Shares short (prior month 15 Mar 2024) 4 | 10.84M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 10 Jul 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:7 |
| Last split date 3 | 10 Jul 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Apr 2023 |
| Most-recent quarter (mrq) | 31 Jan 2024 |
Profitability
| Profit margin | -12.93% |
| Operating margin (ttm) | -11.83% |
Management effectiveness
| Return on assets (ttm) | -2.27% |
| Return on equity (ttm) | -9.67% |
Income statement
| Revenue (ttm) | 136.74M |
| Revenue per share (ttm) | 2.17 |
| Quarterly revenue growth (yoy) | -11.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -6.32M |
| Net income avi to common (ttm) | -17.68M |
| Diluted EPS (ttm) | -0.28 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 30.71M |
| Total cash per share (mrq) | 0.48 |
| Total debt (mrq) | 196.33M |
| Total debt/equity (mrq) | 108.97% |
| Current ratio (mrq) | 0.47 |
| Book value per share (mrq) | 2.84 |
Cash flow statement
| Operating cash flow (ttm) | 12.68M |
| Levered free cash flow (ttm) | -46.99M |
© 2024 Yahoo. All rights reserved.